Hyperion Defi Inc (HYPD)

$4.06 -0.04 (-0.98%)
Market Cap 28.77M
Revenue (ttm) 60,000.00
Net Income (ttm) -49.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 1.19
Profit Margin -83,033.33%
Debt to Equity Ratio 0.11
Volume 687,600
Avg Vol 330,878
Day's Range N/A - N/A
Shares Out 8.17M
Stochastic %K 85%
Beta 2.69
Analysts Strong Sell
Price Target $5.88

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology
Sector: Healthcare
Phone: 917 289 1117
Address:
295 Madison Avenue, Suite 2400, New York, United States
TenYear
TenYear Feb. 3 at 8:52 PM
$HYPD I don’t hate the setup! Insiders bought in December
0 · Reply
SpencerF
SpencerF Feb. 3 at 8:13 PM
$HYPD think we missed the last chance to dump yesterday? Big boys want pennyland next?
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 4:03 PM
$HYPD severely undervalued here. Im projecting once hip4 goes live $HYPE.X goes to new highs target 100 on the coin in 2026, on paper alone they make a 300% return on their coins plus get at least 3mil per quarter on staking and other network rewards. 10x eps brings us to 120mil let alone the free cash they make from optejet 15 to 20 dollar stock just on the above alone.
0 · Reply
Will2ride1
Will2ride1 Feb. 3 at 1:06 PM
$HYPD getting hotter
0 · Reply
Jwelz90
Jwelz90 Feb. 3 at 11:37 AM
$HYPD Days to cover is obviously dropping as volumes increase, but the point is still the same.
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 3:56 AM
$HYPD we are in the right place here family
0 · Reply
Jwa68
Jwa68 Feb. 3 at 3:39 AM
$HYPE.X Aging well. $HYPD
0 · Reply
Jwa68
Jwa68 Feb. 3 at 3:36 AM
$HYPD $PYPL Know what you own...
0 · Reply
StockScanners
StockScanners Feb. 3 at 3:33 AM
$HYPD keep watch if this holds above 3.95
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 2:49 AM
$HYPD $HYPE.X $PURR $HYPE.X should break ath the first q of this year. Until x payments gets their payment platform up this should replace $DOGE.X in the top 10
0 · Reply
Latest News on HYPD
Hyperion DeFi, Inc. (HYPD) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 3:41 PM EST - 2 months ago

Hyperion DeFi, Inc. (HYPD) Q3 2025 Earnings Call Transcript

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 29, 2025, 8:00 AM EDT - 4 months ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

Sep 27, 2025, 7:30 AM EDT - 4 months ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 25, 2025, 8:00 AM EDT - 4 months ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Sep 16, 2025, 8:00 AM EDT - 5 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 14, 2025, 10:16 AM EDT - 6 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:01 PM EDT - 6 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Aug 8, 2025, 4:05 PM EDT - 6 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 28, 2025, 8:00 AM EDT - 6 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 17, 2025, 8:00 AM EDT - 7 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jul 14, 2025, 4:05 PM EDT - 7 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

Jun 18, 2025, 2:04 PM EDT - 8 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL VVPR

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 18, 2025, 8:32 AM EDT - 8 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 3:54 PM EDT - 8 months ago

Eyenovia Surges on Crypto Announcement

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Jun 17, 2025, 2:55 PM EDT - 8 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

May 19, 2025, 5:30 PM EDT - 9 months ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Apr 10, 2025, 7:00 AM EDT - 10 months ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Mar 20, 2025, 7:00 AM EDT - 11 months ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 26, 2025, 7:00 AM EST - 1 year ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 24, 2025, 7:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Feb 5, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 28, 2025, 4:05 PM EST - 1 year ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 15, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Jan 6, 2025, 7:00 AM EST - 1 year ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Eyenovia Provides Update on Restructuring Efforts

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:42 PM EST - 1 year ago

Eyenovia, Inc. (EYEN) Q3 2024 Earnings Call Transcript

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Eyenovia Announces Closing of Public Offering

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Eyenovia, Inc. Announces Proposed Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 11:07 PM EDT - 1 year ago

Eyenovia, Inc. (EYEN) Q2 2024 Earnings Call Transcript

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

NBY

TenYear
TenYear Feb. 3 at 8:52 PM
$HYPD I don’t hate the setup! Insiders bought in December
0 · Reply
SpencerF
SpencerF Feb. 3 at 8:13 PM
$HYPD think we missed the last chance to dump yesterday? Big boys want pennyland next?
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 4:03 PM
$HYPD severely undervalued here. Im projecting once hip4 goes live $HYPE.X goes to new highs target 100 on the coin in 2026, on paper alone they make a 300% return on their coins plus get at least 3mil per quarter on staking and other network rewards. 10x eps brings us to 120mil let alone the free cash they make from optejet 15 to 20 dollar stock just on the above alone.
0 · Reply
Will2ride1
Will2ride1 Feb. 3 at 1:06 PM
$HYPD getting hotter
0 · Reply
Jwelz90
Jwelz90 Feb. 3 at 11:37 AM
$HYPD Days to cover is obviously dropping as volumes increase, but the point is still the same.
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 3:56 AM
$HYPD we are in the right place here family
0 · Reply
Jwa68
Jwa68 Feb. 3 at 3:39 AM
$HYPE.X Aging well. $HYPD
0 · Reply
Jwa68
Jwa68 Feb. 3 at 3:36 AM
$HYPD $PYPL Know what you own...
0 · Reply
StockScanners
StockScanners Feb. 3 at 3:33 AM
$HYPD keep watch if this holds above 3.95
0 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 3 at 2:49 AM
$HYPD $HYPE.X $PURR $HYPE.X should break ath the first q of this year. Until x payments gets their payment platform up this should replace $DOGE.X in the top 10
0 · Reply
insanitywolftrading
insanitywolftrading Feb. 3 at 1:58 AM
$HYPD $HYPE.X $PURR these are all gonna rip tomorrow we caught a big move
0 · Reply
Jstockdaddy
Jstockdaddy Feb. 3 at 1:51 AM
$HYPD has 27% short interest, low float, high insider ownership. This thing is going to explode 💣💣 $HYPE.X $PURR coin trending
0 · Reply
traderk1836
traderk1836 Feb. 3 at 12:00 AM
$HYPD HYPD on Watch as Volume Leads Price https://www.therelativestrengthtrader.com/2026/02/hypd-on-watch-as-volume-leads-price.html
0 · Reply
GSP
GSP Feb. 2 at 11:51 PM
$HYPD is a lower volume stock, but this one looks ready to make a move. .
0 · Reply
UgoGreg
UgoGreg Feb. 2 at 10:19 PM
$HYPD https://youtu.be/ieHlGh9YQxo
0 · Reply
YorkMeister
YorkMeister Feb. 2 at 7:06 PM
$HYPD well done to those who bought (more) this month and understood how massively undervalued this stock is (still). Fair value above $7
1 · Reply
cheating_stock_investor
cheating_stock_investor Feb. 2 at 5:57 PM
$HYPD cryptos have hit a bottom and $HYPE.X has shown resilience through it all..if anything it will break into the top 10 crypto this year. The american version of $BNB.X this should go to ath shortly.
0 · Reply
topstockalerts
topstockalerts Feb. 2 at 5:31 PM
$HYPD Buyers remain active as price moves higher. Pullbacks are being bought. Momentum remains bullish.
1 · Reply
Jwelz90
Jwelz90 Feb. 2 at 5:18 PM
$HYPD 👀👀👀
0 · Reply
Jstockdaddy
Jstockdaddy Feb. 2 at 2:42 PM
$HYPD $HYPE.X $PURR blowing up today
0 · Reply
UgoGreg
UgoGreg Jan. 31 at 4:29 PM
$HYPD https://youtu.be/tAh290QykVA
0 · Reply
SteveStachion
SteveStachion Jan. 31 at 2:35 AM
$HYPD $HYPE.X $PURR 👇👇👇
0 · Reply